Sign Up to like & get
recommendations!
1
Published in 2022 at "Expert Opinion on Investigational Drugs"
DOI: 10.1080/13543784.2022.2052042
Abstract: ABSTRACT Introduction KSI-301 is an intravitreal anti-vascular endothelial growth factor (VEGF) agent in clinical trials for the treatment of neovascular age-related macular degeneration (nAMD), diabetic retinopathy, diabetic macular edema (DME), and retinal vein occlusion (RVO).…
read more here.
Keywords:
ksi 301;
vegf;
anti vegf;
investigational anti ... See more keywords
Sign Up to like & get
recommendations!
3
Published in 2023 at "Expert opinion on investigational drugs"
DOI: 10.1080/13543784.2023.2215425
Abstract: INTRODUCTION IL-13 is a pleiotropic type 2 cytokine important in the pathogenesis of asthma and other eosinophilic disorders. AREAS COVERED Different attempts to directly neutralise IL-13 or block its receptors and the possible impact that…
read more here.
Keywords:
2023 update;
asthma treatments;
asthma;
anti asthma ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Journal of Cardiovascular Pharmacology"
DOI: 10.1097/fjc.0000000000000892
Abstract: Abstract: Antiarrhythmic drugs remain the mainstay therapy for patients with atrial fibrillation (AF). A major disadvantage of the currently available anti-AF agents is the risk of induction of ventricular proarrhythmias. Aiming to reduce this risk,…
read more here.
Keywords:
investigational anti;
pharmacology;
atrial fibrillation;
anti atrial ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.tps3146
Abstract: TPS3146Background: While immune surveillance plays a critical role in preventing tumor proliferation and metastasis, tumors develop resistance mechanisms to suppress and/or escape the immune system...
read more here.
Keywords:
anti tim;
antibody;
a425 investigational;
investigational anti ... See more keywords